{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:28:20Z","timestamp":1783632500782,"version":"3.55.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cellsig.2020.109730","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T21:49:48Z","timestamp":1595886588000},"page":"109730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Increased mTOR and suppressed autophagic flux in the heart of a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"74","author":[{"given":"Daniel J.","family":"Atwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Pokhrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn N.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Holditch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheevena M.","family":"Bachu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Thorburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-2358","authenticated-orcid":false,"given":"Katharina","family":"Hopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cellsig.2020.109730_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","author":"Wilson","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109730_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.med.45.1.23","article-title":"Natural history of autosomal dominant polycystic kidney disease","volume":"45","author":"Fick","year":"1994","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0020","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1038\/s41598-018-23732-5","article-title":"Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells","volume":"8","author":"Di Mise","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2020.109730_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fmolb.2018.00077","article-title":"Activation of the calcium-sensing receptor corrects the impaired mitochondrial energy status observed in renal polycystin-1 knockdown cells modeling autosomal dominant polycystic kidney disease","volume":"5","author":"Di Mise","year":"2018","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semnephrol.2013.11.005","article-title":"Polycystic kidney disease: a case of suppressed autophagy?","volume":"34","author":"Ravichandran","year":"2014","journal-title":"Semin. Nephrol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0035","first-page":"158","article-title":"Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model","volume":"26","author":"Zhu","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00441-017-2628-6","article-title":"Role of apoptosis in the development of autosomal dominant polycystic kidney disease (ADPKD)","volume":"369","author":"Peintner","year":"2017","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cellsig.2020.109730_bb0045","doi-asserted-by":"crossref","first-page":"109518","DOI":"10.1016\/j.cellsig.2019.109518","article-title":"Apoptosis and autophagy in polycystic kidney disease (PKD)","volume":"68","author":"Nowak","year":"2020","journal-title":"Cell. Signal."},{"issue":"12","key":"10.1016\/j.cellsig.2020.109730_bb0050","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"Fick","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109730_bb0055","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109730_bb0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cellsig.2020.109730_bb0065","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2020.109730_bb0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cardiores.2004.02.003","article-title":"Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy","volume":"63","author":"Proud","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109730_bb0075","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease","volume":"78","author":"Zafar","year":"2010","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109730_bb0080","doi-asserted-by":"crossref","first-page":"F349","DOI":"10.1152\/ajprenal.00478.2014","article-title":"Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2","volume":"308","author":"Ravichandran","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109730_bb0085","doi-asserted-by":"crossref","first-page":"e9239","DOI":"10.1371\/journal.pone.0009239","article-title":"Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR","volume":"5","author":"Dere","year":"2010","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.cellsig.2020.109730_bb0090","first-page":"1591","article-title":"Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin","volume":"466","author":"Mekahli","year":"2014","journal-title":"Pflugers Arch."},{"issue":"14","key":"10.1016\/j.cellsig.2020.109730_bb0095","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-8417-2-6","article-title":"Emerging evidence of a link between the polycystins and the mTOR pathways","volume":"2","author":"Boletta","year":"2009","journal-title":"Pathogenetics"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109730_bb0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/stem.2764","article-title":"Polycystin-2 plays an essential role in glucose starvation-induced autophagy in human embryonic stem cell-derived cardiomyocytes","volume":"36","author":"Lu","year":"2018","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109730_bb0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109730_bb0120","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","article-title":"AMPK and TOR: the Yin and Yang of cellular nutrient sensing and growth control","volume":"31","author":"Gonzalez","year":"2020","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.cellsig.2020.109730_bb0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","article-title":"AMPK: an energy-sensing pathway with multiple inputs and outputs","volume":"26","author":"Hardie","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2020.109730_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1113\/jphysiol.2006.108944","article-title":"AMP-activated protein kinase--development of the energy sensor concept","volume":"574","author":"Hardie","year":"2006","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109730_bb0135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4161\/auto.4240","article-title":"AMP-activated protein kinase: a universal regulator of autophagy?","volume":"3","author":"Hoyer-Hansen","year":"2007","journal-title":"Autophagy."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109730_bb0140","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity","volume":"122","author":"Hopp","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1681\/ASN.2013121312","article-title":"Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model","volume":"26","author":"Hopp","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.cellsig.2020.109730_bb0150","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.kint.2018.06.025","article-title":"CD8(+) T cells modulate autosomal dominant polycystic kidney disease progression","volume":"94","author":"Kleczko","year":"2018","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0155","doi-asserted-by":"crossref","first-page":"F187","DOI":"10.1152\/ajprenal.00051.2019","article-title":"A study of sirolimus and an mTOR kinase inhibitor (TORKi) in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease (ADPKD)","volume":"317","author":"Holditch","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(98)00073-X","article-title":"Cardiovascular phenotyping in mice","volume":"39","author":"Doevendans","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109730_bb0165","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4161\/auto.5.4.7760","article-title":"Autophagy induced by 2-deoxy-D-glucose suppresses intracellular multiplication of Legionella pneumophila in A\/J mouse macrophages","volume":"5","author":"Matsuda","year":"2009","journal-title":"Autophagy"},{"issue":"16","key":"10.1016\/j.cellsig.2020.109730_bb0170","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/pros.20837","article-title":"Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy","volume":"68","author":"DiPaola","year":"2008","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109730_bb0175","doi-asserted-by":"crossref","first-page":"e17234","DOI":"10.1371\/journal.pone.0017234","article-title":"2-Deoxy-D-glucose treatment of endothelial cells induces autophagy by reactive oxygen species-mediated activation of the AMP-activated protein kinase","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cellsig.2020.109730_bb0180","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1080\/15548627.2016.1215382","article-title":"Hypothalamic AMPK-induced autophagy increases food intake by regulating NPY and POMC expression","volume":"12","author":"Oh","year":"2016","journal-title":"Autophagy"},{"issue":"13","key":"10.1016\/j.cellsig.2020.109730_bb0185","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/pros.21172","article-title":"Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies","volume":"70","author":"Stein","year":"2010","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.cellsig.2020.109730_bb0190","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00280-010-1391-0","article-title":"2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion","volume":"67","author":"Xi","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"13","key":"10.1016\/j.cellsig.2020.109730_bb0195","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","article-title":"Drp1-dependent mitochondrial autophagy plays a protective role against pressure overload-induced mitochondrial dysfunction and heart failure","volume":"133","author":"Shirakabe","year":"2016","journal-title":"Circulation"},{"issue":"7436","key":"10.1016\/j.cellsig.2020.109730_bb0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11866","article-title":"Identification of a candidate therapeutic autophagy-inducing peptide","volume":"494","author":"Shoji-Kawata","year":"2013","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.cellsig.2020.109730_bb0205","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1161\/CIRCULATIONAHA.117.032821","article-title":"Beclin-1-dependent autophagy protects the heart during sepsis","volume":"138","author":"Sun","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ndt\/gfu296","article-title":"An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease (PKD)","volume":"30","author":"Ravichandran","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"issue":"18","key":"10.1016\/j.cellsig.2020.109730_bb0220","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1093\/hmg\/ddu208","article-title":"An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2","volume":"23","author":"Ravichandran","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"6762","key":"10.1016\/j.cellsig.2020.109730_bb0225","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","volume":"402","author":"Liang","year":"1999","journal-title":"Nature"},{"issue":"7148","key":"10.1016\/j.cellsig.2020.109730_bb0230","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nature05925","article-title":"Ambra1 regulates autophagy and development of the nervous system","volume":"447","author":"Fimia","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000343419","article-title":"Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner","volume":"36","author":"Pietrzak-Nowacka","year":"2012","journal-title":"Kidney Blood Press. Res."},{"issue":"10","key":"10.1016\/j.cellsig.2020.109730_bb0240","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2215\/CJN.04610511","article-title":"Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease","volume":"6","author":"Perrone","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109730_bb0245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijcard.2018.10.063","article-title":"Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: a cross-sectional and longitudinal substudy of the ALADIN trial","volume":"275","author":"Spinelli","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109730_bb0250","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/hep.23511","article-title":"Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice","volume":"51","author":"Spirli","year":"2010","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.cellsig.2020.109730_bb0255","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","article-title":"Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload","volume":"109","author":"McMullen","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cellsig.2020.109730_bb0260","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","article-title":"Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice","volume":"123","author":"Shende","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cvr\/cvv252","article-title":"Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy","volume":"109","author":"Shende","year":"2016","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.cellsig.2020.109730_bb0270","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI43008","article-title":"MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice","volume":"120","author":"Zhang","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.cellsig.2020.109730_bb0275","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"7","key":"10.1016\/j.cellsig.2020.109730_bb0280","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell."},{"key":"10.1016\/j.cellsig.2020.109730_bb0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbior.2017.06.003","article-title":"GSK3 and its interactions with the PI3K\/AKT\/mTOR signalling network","volume":"65","author":"Hermida","year":"2017","journal-title":"Adv. Biol. Regul."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109730_bb0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem. Sci."},{"issue":"6559","key":"10.1016\/j.cellsig.2020.109730_bb0295","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cellsig.2020.109730_bb0300","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1247\/csf.27.421","article-title":"Autophagosome formation in mammalian cells","volume":"27","author":"Mizushima","year":"2002","journal-title":"Cell Struct. Funct."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0305","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/cr.2013.161","article-title":"Autophagy and human diseases","volume":"24","author":"Jiang","year":"2014","journal-title":"Cell Res."},{"issue":"7182","key":"10.1016\/j.cellsig.2020.109730_bb0310","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0315","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-biophys-060414-034248","article-title":"Mechanisms of autophagy","volume":"44","author":"Noda","year":"2015","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.cellsig.2020.109730_bb0320","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature08455","article-title":"Discovery of Atg5\/Atg7-independent alternative macroautophagy","volume":"461","author":"Nishida","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cellsig.2020.109730_bb0325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0330","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42255-019-0157-1","article-title":"mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress","volume":"2","author":"Ling","year":"2020","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.cellsig.2020.109730_bb0335","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","article-title":"2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109730_bb0340","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2020.109730_bb0345","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ekir.2019.12.007","article-title":"Polycystins, ADPKD, and cardiovascular disease","volume":"5","author":"Kuo","year":"2020","journal-title":"Kidney Int. Rep."},{"issue":"11","key":"10.1016\/j.cellsig.2020.109730_bb0350","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00424-017-2042-7","article-title":"Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress","volume":"469","author":"Giehl","year":"2017","journal-title":"Pflugers Arch."},{"issue":"24","key":"10.1016\/j.cellsig.2020.109730_bb0355","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.114.013537","article-title":"Polycystin-1 is a cardiomyocyte mechanosensor that governs L-type Ca2+ channel protein stability","volume":"131","author":"Pedrozo","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cellsig.2020.109730_bb0360","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0272-6386(98)70071-X","article-title":"Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease","volume":"32","author":"Bardaji","year":"1998","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2020.109730_bb0365","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.V1051020","article-title":"Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease","volume":"10","author":"Valero","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0370","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1038\/s41467-018-07188-9","article-title":"The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance","volume":"9","author":"Han","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2020.109730_bb0375","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-017-0648-1","article-title":"ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2020.109730_bb0380","doi-asserted-by":"crossref","first-page":"4629495","DOI":"10.1155\/2017\/4629495","article-title":"Multifaceted roles of GSK-3 in cancer and autophagy-related diseases","volume":"2017","author":"Mancinelli","year":"2017","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820302072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820302072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:56:59Z","timestamp":1760266619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656820302072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":76,"alternative-id":["S0898656820302072"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109730","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased mTOR and suppressed autophagic flux in the heart of a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109730"}}